Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 3/20 | 0.49 |
| ▸ | MAOA | P21397 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | PPARG | P37231 | 2/20 | 0.47 |
| ▸ | PPARA | Q07869 | 2/20 | 0.47 |
| ▸ | BCHE | P06276 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2600693 | 0.84 | SIGMAR1 (0.47) | SIGMAR1MAOAMEN1KMT2ASLC6A2 | |
| SCHEMBL12621036 | 0.84 | SIGMAR1 (0.47) | SIGMAR1MAOAMEN1KMT2ASLC6A2 | |
| SCHEMBL12103354 | 0.84 | SIGMAR1 (0.47) | SIGMAR1MAOAMEN1KMT2ASLC6A2 | |
| SCHEMBL13537546 | 0.84 | SIGMAR1 (0.47) | SIGMAR1MAOAMEN1KMT2ASLC6A2 | |
| SCHEMBL2600702 | 0.84 | SIGMAR1 (0.47) | SIGMAR1MAOAMEN1KMT2ASLC6A2 | |
| SCHEMBL13534760 | 0.84 | SIGMAR1 (0.47) | SIGMAR1MAOAMEN1KMT2ASLC6A2 | |
| SCHEMBL6840473 | 0.84 | SIGMAR1 (0.47) | SIGMAR1MAOAMEN1KMT2ASLC6A2 | |
| SCHEMBL4607825 | 0.83 | LTA4H (0.57) | LTA4HSIGMAR1MAOBMAOARAB9A | |
| SCHEMBL1817589 | 0.83 | LTA4H (0.57) | LTA4HSIGMAR1MAOBMAOARAB9A | |
| Dimethylamine SCHEMBL29014940 | 0.80 | SIGMAR1 (0.48) | SIGMAR1MAOASLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170253607-A1 | LONG-ACTING HIV PROTEASE INHIBITOR | SHIONOGI & CO., LTD. (JP) | 2017-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170253607-A1 | LONG-ACTING HIV PROTEASE INHIBITOR | CPN1, HAT1, PRSS1 | LTA4H 983/4885SIGMAR1 160/4885MAOB 1362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.